Literature DB >> 1986386

Pancreatic tumor pathogenesis reflects the causative genetic lesion.

E P Sandgren1, C J Quaife, A G Paulovich, R D Palmiter, R L Brinster.   

Abstract

Transgenic mice in which c-myc expression is targeted to pancreatic acinar cells develop mixed acinar/ductal pancreatic adenocarcinomas between 2 and 7 months of age. This contrasts with the effect on pancreas of the simian virus 40 tumor antigen or activated ras, which in adult mice causes lesions composed exclusively of acinar-like cells. Furthermore, during an early stage of myc-induced pathology, transformed acinar-derived cells appear within islets, suggesting that islet hormones may influence the progression of these exocrine pancreatic tumors. These findings demonstrate that the initial oncogenic alteration can influence the pattern of subsequent tumor pathogenesis and, given that human exocrine pancreatic tumors are predominantly ductal adenocarcinomas, support the suggestion that transformed acinar cells may contribute to the genesis of this serious disease in man.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1986386      PMCID: PMC50755          DOI: 10.1073/pnas.88.1.93

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  25 in total

1.  Pancreatic neoplasia induced by SV40 T-antigen expression in acinar cells of transgenic mice.

Authors:  D M Ornitz; R E Hammer; A Messing; R D Palmiter; R L Brinster
Journal:  Science       Date:  1987-10-09       Impact factor: 47.728

Review 2.  The myc oncogene: its role in transformation and differentiation.

Authors:  M D Cole
Journal:  Annu Rev Genet       Date:  1986       Impact factor: 16.830

Review 3.  The molecular genetics of cancer.

Authors:  J M Bishop
Journal:  Science       Date:  1987-01-16       Impact factor: 47.728

4.  Factors affecting the efficiency of introducing foreign DNA into mice by microinjecting eggs.

Authors:  R L Brinster; H Y Chen; M E Trumbauer; M K Yagle; R D Palmiter
Journal:  Proc Natl Acad Sci U S A       Date:  1985-07       Impact factor: 11.205

5.  Pancreatic neoplasia induced by ras expression in acinar cells of transgenic mice.

Authors:  C J Quaife; C A Pinkert; D M Ornitz; R D Palmiter; R L Brinster
Journal:  Cell       Date:  1987-03-27       Impact factor: 41.582

Review 6.  Tumor cell instability, diversification, and progression to the metastatic phenotype: from oncogene to oncofetal expression.

Authors:  G L Nicolson
Journal:  Cancer Res       Date:  1987-03-15       Impact factor: 12.701

7.  Immunocytochemical markers of uncommon pancreatic tumors. Acinar cell carcinoma, pancreatoblastoma, and solid cystic (papillary-cystic) tumor.

Authors:  T Morohoshi; M Kanda; A Horie; A Chott; T Dreyer; G Klöppel; P U Heitz
Journal:  Cancer       Date:  1987-02-15       Impact factor: 6.860

8.  Specific expression of an elastase-human growth hormone fusion gene in pancreatic acinar cells of transgenic mice.

Authors:  D M Ornitz; R D Palmiter; R E Hammer; R L Brinster; G H Swift; R J MacDonald
Journal:  Nature       Date:  1985 Feb 14-20       Impact factor: 49.962

9.  Erythroid-specific expression of human beta-globin genes in transgenic mice.

Authors:  T M Townes; J B Lingrel; H Y Chen; R L Brinster; R D Palmiter
Journal:  EMBO J       Date:  1985-07       Impact factor: 11.598

Review 10.  Histogenesis of exocrine pancreatic cancer in the hamster model.

Authors:  P M Pour
Journal:  Environ Health Perspect       Date:  1984-06       Impact factor: 9.031

View more
  54 in total

1.  Aberrant signaling pathways in pancreatic cancer: a two compartment view.

Authors:  Angela L McCleary-Wheeler; Robert McWilliams; Martin E Fernandez-Zapico
Journal:  Mol Carcinog       Date:  2012-01       Impact factor: 4.784

Review 2.  Pancreatic ductal adenocarcinoma and transcription factors: role of c-Myc.

Authors:  Anouchka Skoudy; Inmaculada Hernández-Muñoz; Pilar Navarro
Journal:  J Gastrointest Cancer       Date:  2011-06

Review 3.  Transgenic models of pancreatic cancer.

Authors:  Andrew M Lowy
Journal:  Int J Gastrointest Cancer       Date:  2003

4.  Exploiting oncogene-induced replicative stress for the selective killing of Myc-driven tumors.

Authors:  Matilde Murga; Stefano Campaner; Andres J Lopez-Contreras; Luis I Toledo; Rebeca Soria; Maria F Montaña; Luana D' Artista; Thomas Schleker; Carmen Guerra; Elena Garcia; Mariano Barbacid; Manuel Hidalgo; Bruno Amati; Oscar Fernandez-Capetillo
Journal:  Nat Struct Mol Biol       Date:  2011-11-27       Impact factor: 15.369

5.  HPAC, a new human glucocorticoid-sensitive pancreatic ductal adenocarcinoma cell line.

Authors:  W R Gower; R M Risch; C V Godellas; P J Fabri
Journal:  In Vitro Cell Dev Biol Anim       Date:  1994-03       Impact factor: 2.416

6.  Activated Kras and Ink4a/Arf deficiency cooperate to produce metastatic pancreatic ductal adenocarcinoma.

Authors:  Andrew J Aguirre; Nabeel Bardeesy; Manisha Sinha; Lyle Lopez; David A Tuveson; James Horner; Mark S Redston; Ronald A DePinho
Journal:  Genes Dev       Date:  2003-12-17       Impact factor: 11.361

7.  The c-myc and PyMT oncogenes induce different tumor types in a somatic mouse model for pancreatic cancer.

Authors:  Brian C Lewis; David S Klimstra; Harold E Varmus
Journal:  Genes Dev       Date:  2003-12-17       Impact factor: 11.361

8.  Galectin-1 drives pancreatic carcinogenesis through stroma remodeling and Hedgehog signaling activation.

Authors:  Neus Martínez-Bosch; Maite G Fernández-Barrena; Mireia Moreno; Elena Ortiz-Zapater; Jessica Munné-Collado; Mar Iglesias; Sabine André; Hans-Joachim Gabius; Rosa F Hwang; Françoise Poirier; Carolina Navas; Carmen Guerra; Martin E Fernández-Zapico; Pilar Navarro
Journal:  Cancer Res       Date:  2014-05-08       Impact factor: 12.701

9.  Trypsinogen expression by two human pancreatic cell lines CFPAC-1 and CAPAN-1. Modulation during spontaneous and induced cell growth.

Authors:  B Miszczuk-Jamska; M Merten; W Renaud; O Guy-Crotte; C Figarella
Journal:  Int J Pancreatol       Date:  1994-08

10.  Notch and Kras in pancreatic cancer: at the crossroads of mutation, differentiation and signaling.

Authors:  Jean-Paul De La O; L Charles Murtaugh
Journal:  Cell Cycle       Date:  2009-06-15       Impact factor: 4.534

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.